Stylianou E, Saklatvala J
School of Medical and Surgical Sciences, University Hospital, Queen's Medical Centre, Nottingham, UK.
Int J Biochem Cell Biol. 1998 Oct;30(10):1075-9. doi: 10.1016/s1357-2725(98)00081-8.
Interleukin 1 (IL1) is a primary regulator of inflammatory and immune responses. Via its type I receptor it activates specific protein kinases, including the NF kappa B inducing kinase (NIK) and three distinct mitogen-activated protein (MAP) kinase cascades. These modulate a number of transcription factors including NF kappa B, AP1 and CREB each of which regulate a plethora of immediate early genes central to the inflammatory response. Phase I clinical trials of the soluble type I receptor and IRAP indicate that these have potential anti-inflammatory effects.
白细胞介素1(IL1)是炎症和免疫反应的主要调节因子。通过其I型受体,它激活特定的蛋白激酶,包括NF-κB诱导激酶(NIK)和三种不同的丝裂原活化蛋白(MAP)激酶级联反应。这些调节多种转录因子,包括NF-κB、AP1和CREB,它们各自调节大量对炎症反应至关重要的即刻早期基因。可溶性I型受体和IRAP的I期临床试验表明,它们具有潜在的抗炎作用。